Oncology research news from Australia and around the world
Phase 2 LITESPARK-003 results suggest continued study of novel first-line combo for advanced kidney cancer
RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal…